Oxygenta Pharmaceutical Ltd — Important, 11-12-2025: Company Update

Oxygenta Pharmaceutical's shareholders have approved reclassifying four individuals from the Promoter/Promoter Group to the Public Category. These outgoing promoters, including Mr. Sai Sudhakar Vankineni and Ms. Snigdha Vankineni, collectively held 0.94 Cr shares, representing 2.55% of the company's paid-up capital. This reclassification ensures they no longer hold more than 10% of shares, exercise control, or have board representation. This strategic move aligns the company with public shareholding requirements and immediately increases its public float.